Merck Solidifies RCC Position, While Bristol Gets Good SubQ Readout

 
• By Joseph Haas
  
Merck_New_Jersey
Merck demonstrates an overall survival benefit with Keytruda in RCC
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business